NCT07544953 Amyloid Monoclonal Antibody Treatment in PD Patients With Coexistent AD Pathology Status NOT_YET_RECRUITING Phase NA
NCT06602258 A Study of E2814 With Concurrent Lecanemab Treatment in Participants With Early Alzheimer's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT06530732 Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study) Status RECRUITING Phase PHASE3
NCT06384573 DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT06285448 Feasibility of Lecanemab Registry and Clinical Outcome Measures Status ENROLLING_BY_INVITATION Phase N/A
NCT05533801 A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Status COMPLETED Phase PHASE1
NCT05469009 Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) Therapy Status ACTIVE_NOT_RECRUITING Phase EARLY_PHASE1
NCT05269394 Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04468659 AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01760005 Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3